EUVIMEDSkopri EUVIMED
Crossref

Impact of antithrombotics on the fecal immunochemical test for colorectal cancer screening : a multi-center Belgian experience

L Wauters, V R H Van der Voort, P Dobbels, K Hendrickx, V Casneuf, J Vandervoort

Acta Gastro Enterologica Belgica · 2021

DOI: 10.51821/84.1.349 ↗

At a glance

Journal article in Acta Gastro Enterologica Belgica, 2021. Written by L Wauters and 5 co-authors. Institution: Department of Gastroenterology and Hepatology, UZ Leuven, Leuven, Belgium and Translational Research Center for Gastrointestinal Disorders (TARGID), …. Major MEDLINE topics: Colorectal Neoplasms, Fibrinolytic Agents. Cited 2 times so far (Crossref); 19 references.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Background

Impact of antithrombotics on the fecal immunochemical test (FIT) for colorectal cancer (CRC) screening remains unclear.

Methods

Patients undergoing colonoscopy for positive FIT in 2015 were assessed at 3 Belgian centers. Significant findings were advanced polyps (AP) (sessile serrated, tubular or villous adenomas >1cm or high-grade dysplasia) and CRC. False positive FIT and detection of AP/CRC with antithrombotics were calculated.

Results

510 patients (64% male, median (IQR) age 63.2 (60.2-66.4) years) were included. Colorectal pathology in 371/510 (73%) was associated with male gender (70% vs. 48% ; p= .0001) and family history (16% vs. 8% ; p= .02). Antithrombotics in 125/510 (25%) were associated with male gender (78% vs. 59% ; p= .0001), older age (65.2 (62.2-70.3) vs. 62.3 (58.7-66.3) years ; p= .0001) and GI-symptoms (18% vs. 11% ; p= .04). False positive FIT (25% vs. 28% ; p= .52) and detection of AP (42% vs. 36% ; p= .27) or CRC (6% vs. 5% ; p= .69) were similar in patients with vs. no antithrombotics. Use of antithrombotics did not predict a higher chance of colorectal pathology after adjusting for confounders.

Conclusion

Although antithrombotics were prescribed more frequently in male and older patients, detection of AP/CRC was similar. Despite increased GI symptoms, false positive FIT was similar with antithrombotics.

Subjects

MeSH terms (MEDLINE)

Colorectal NeoplasmsFibrinolytic AgentsAgedBelgiumColonoscopyEarly Detection of CancerFecesFemaleHumansMaleMass ScreeningMiddle Aged

Author keywords

antithromboticsaspirincolon cancerfecal immunochemical testscreening

Substances

Fibrinolytic Agents

Authors and institutions

  • Department of Gastroenterology and Hepatology, UZ Leuven, Leuven, Belgium and Translational Research Center for Gastrointestinal Disorders (TARGID), KU Leuven, Leuven, Belgium.
  • Department of Gastroenterology, UMC Utrecht, Utrecht, The Netherlands.
  • Department of Gastroenterology, OLV Hospitals Aalst/Asse/Ninove, Aalst, Belgium.
  • Department of Gastroenterology, UZ Gent, Gent, Belgium.

Cite

APA

Wauters, L., Van der Voort, V. R. H., Dobbels, P., Hendrickx, K., Casneuf, V., & Vandervoort, J. (2021). Impact of antithrombotics on the fecal immunochemical test for colorectal cancer screening : a multi-center Belgian experience. Acta Gastro Enterologica Belgica. https://doi.org/10.51821/84.1.349

Vancouver

Wauters L, Van der Voort VRH, Dobbels P, Hendrickx K, Casneuf V, Vandervoort J. Impact of antithrombotics on the fecal immunochemical test for colorectal cancer screening : a multi-center Belgian experience. Acta Gastro Enterologica Belgica. 2021. doi:10.51821/84.1.349

BibTeX
@article{Wauters2021,
  author = {Wauters, L and Van der Voort, V R H and Dobbels, P and Hendrickx, K and Casneuf, V and Vandervoort, J},
  title = {Impact of antithrombotics on the fecal immunochemical test for colorectal cancer screening : a multi-center Belgian experience},
  journal = {Acta Gastro Enterologica Belgica},
  year = {2021},
  doi = {10.51821/84.1.349}
}
Start for free →